Connect with us

Health

Experimental COVID-19 Vaccine Shows 95% Effectiveness – Pfizer, BioNTech

Published

on

Pfizer and BioNTech said Wednesday that a completed study of their experimental Covid-19 vaccine showed it was 95 percent effective.

They said the two-dose vaccine had no serious safety concerns and that the companies will apply for emergency use authorization from US regulators “within days.”

The announcement came as coronavirus cases are surging in the US and other parts of the world, and boosted hopes for an end to the pandemic that has upended life around the globe.

“The study results mark an important step in this historic eight-month journey to bring forward a vaccine capable of helping to end this devastating pandemic,” said Pfizer CEO Albert Bourla.

“With hundreds of thousands of people around the globe infected every day, we urgently need to get a safe and effective vaccine to the world,” he added.

Pfizer had said last week after a preliminary analysis that its product was more than 90 percent effective.

On Monday another biotech firm involved in the race to develop a vaccine, Moderna, said its own vaccine was 94.5 percent effective, according to a preliminary analysis.

Pfizer has previously said it expected to contact the US Food and Drug Administration to apply for an Emergency Use Authorization by the third week of November.

ALSO READ  Indiscriminate Waste Disposal : Oyo Govt.  to Set Up Environmental Tribunals 

The FDA had imposed a requirement on Covid-19 vaccine makers of having at least two months of follow-up with volunteers after their second dose, taken 28 days after the first, in order to ensure the drugs are safe.

Moderna developed its vaccine along with the US National Institutes for Health.

Both vaccines use mRNA (messenger ribonucleic acid) technology to deliver genetic material to the body that makes human cells create a protein from the virus.

This trains the immune system to be ready to attack if it encounters SARS-CoV-2.

Other vaccines that are in late-stage trials, such as one being developed by Johnson & Johnson and another by Oxford University and AstraZeneca, use modified viruses to deliver genetic material for the same purpose.

No mRNA vaccines have ever been approved, but Anthony Fauci, the United States’ top infectious disease scientist, told AFP Tuesday the technology had now “established itself.”

-AFP

Comments

Health

Fg begins online registration for COVID-19 vaccination {Read details}

Published

on

By

The National Primary Health Care Development Agency has announced that Nigerians can now register for the COVID-19 vaccination through its official website.

The agency on Monday in a tweet explained, “To register for #COVID19 Vaccination, visit our website http://nphcda.gov.ng and click on ‘COVID-19 Vaccination e-registration”.

Nigeria is expected to receive almost four million doses of the vaccine tomorrow courtesy of COVAX, a global initiative backed by the World Health Organisation.

Earlier on Monday, the Minister of State for Health, Dr Olorunnimbe Mamora, noted that frontline health workers would be one of the first set of people to get the vaccine.

“The first will be the frontline health workers because they are facing the battle heavily,” he said.

“They will come first then, secondly, we will look at the elderly – those above 60, 65 years and particularly with comorbidities (people who have existing health conditions such as high blood pressure, diabetes, heart disease – they will also be in that group.

“We will also be looking and the strategic leadership of the country, and then we would be looking at some other people like those at the point of entry, border post managers, and things like that; This will be the order in terms of priority for now.”

ALSO READ  UI Finally Lifts Ban On Students’ Union Activities
Continue Reading

Health

Nigeria to receive about 4m doses of COVID-19 vaccine on Tuesday

Published

on

By

The Nigerian government has confirmed that it will receive the first tranche of the COVID-19 vaccine on Tuesday.

Chairman of the Presidential Task Force (PTF) on COVID-19, Boss Mustapha  disclosed this on Saturday in Abuja, the Nation’s capital. 

Boss Mustapha, who also doubles as the Secretary to the Government of the Federation (SGF), explained that the first shipment of  3,924,000 million doses of covid-19 vaccines is coming from COVAX, a World Health Organization (WHO) backed initiative set up to procure and ensure equitable distribution of vaccines for free among countries across the globe.

“I can assure you that the vaccines are coming and they are coming very quickly barring any change in the delivery plan that has been released to us by UNICEF,” the SGF said, exactly one year after the virus was reported in the West African nation.

The SGF continued , “We believe that our vaccines should depart India on the 1st of March, 2021 at 10:30 pm and arrive in Abuja on the 2nd of March by 11:10 am.”

The Minister of Health, Dr Osagie Ehanire had earlier confirmed that Nigeria will be getting the COVAX vaccine in March, and explained that the Federal Government is targeting to vaccinate 70 percent of the population. 

“We have been told to open an account with Afreximbank under the African Union; we have done that already successfully because we are going to pay for that part of the vaccine. The COVAX vaccine is free, at no cost to us, it is made from donations,” the minister had explained during a briefing with journalists

“We want to immunise about 60 to 70% of our population. If COVAX immunises 20, then we have about 40 to 50 to immunise within the next two years”,  he said

ALSO READ  ‘What would Atiku do differently?’ — Buhari asks Nigerians in state broadcast
Continue Reading

Health

Why the US has the highest COVID-19 death toll

Published

on

By

The United States crossed the grim milestone of 500,000 deaths from COVID-19 on Monday, a year since announcing its first known death from the virus on February 29, 2020 in the Seattle area.

Why does the world’s leading power have the highest death toll and what lessons are American health specialists learning from the past year?

Here, infectious disease experts Joseph Masci and Michele Halpern provide answers to some of the key questions.

Masci, 70, is one of the leaders of Elmhurst Hospital in Queens, which was at the heart of New York’s epidemic.

Halpern is a specialist at the Montefiore hospital group in New Rochelle, a New York suburb where the epidemic arrived in force in February 2020.

– Why has the United States been hit so hard? –

Prior to this pandemic, the United States observed coronaviruses “from a distance,” explained Masci.

“There was SARS in Canada but very little or none in this country. There was no MERS here at all,” he said.

“There was a lot of preparation made for Ebola coming to the United States, and it never really did.

“Suddenly this (coronavirus) was a problem where the United States was the epicenter.”

Masci said it was difficult to compare the United States with other countries.

“I think smaller countries that had structured health care services had a good chance of bringing things into play quickly.

“In a country like ours, with 50 independent states, and a huge landmass, with largely a private hospital system, it is always going to be difficult to get everybody on board with one particular set of strategies,” he explained.

Masci added that Donald Trump’s administration had a “haphazard approach”, which did not help.

“The fact that hospitals were competing with each other to get personal protective equipment didn’t make sense. They had to centralize all of that very quickly and they didn’t.

“It was a struggle to try to deal with those obstacles that were put up,” he said.

Masci and Halpern rue that mask-wearing was politicized.

“It’s purely a health care issue,” said Masci, adding that it is going to be difficult for the federal government to “reframe” that message.

Halpern insists that people should not see mask-wearing as “infringing” on their freedom.

“There are other things we do routinely that you could say infringe our liberties like wearing a seatbelt or running through a red light,” she said.

According to the Johns Hopkins University tally, another 1,297 virus-related deaths were reported on Monday in the United States.

– What are the main lessons to be learned from the crisis? –

For Masci, the most important lesson was to learn how to reconfigure hospitals to make them able to cope with a sudden influx of patients.

“Now… instead of 12 hot ICU beds, you have to have 150. Where do you get them? Who do you staff on with? So now we’ve learned this lesson.” he said.

Masci said the group of public hospitals of which Elmhurst is a part found strategies to distribute the burden among NYC’s 11 public hospitals by transferring patients very quickly.

“We’ve turned from one hospital with 500 beds, to 11 hospitals with about 5,000 beds. It’s worked very nicely.”

More generally, Halpern says the pandemic has made everyone realize that “hospitals need resources.”

“You have to invest in research, but you also have to invest in hospitals, in nursing homes. They have to have enough staff, they have to have the equipment that they need and the personnel has to be happy,” she added.

The epidemic has also sharply exposed inequalities, not just in health care but also in housing, with Black and Latino communities dying in disproportionately high numbers.

“We have to look at housing, and how it can be better suited to handling future epidemics. There are others coming,” said Masci.

– Will we still be wearing masks in December? –

Vaccines are rolling out but health experts are cautious due to uncertainties surrounding the British and South African variants of the virus.

Masci says that if the variant strains don’t turn into a huge problem and once we’ve reached the point where 70-80 percent of the population is vaccinated then “there’s a good chance” we won’t wear masks anymore.

“(But) suppose these variant strains do take hold, become more of a problem, are vaccine resistant, and we’re all closing schools and putting masks and locking down again in a few months, (then) it’s a lot harder to say by December, ‘We’ll be out of the woods.’”

Halpern says it’s reassuring that the second wave was largely controlled, in New York at least.

“I have hopes that the vaccines will be effective and will tamper future waves. But it’s hard to be sure whether our vaccines will be effective in the longer term, or on new variants. I don’t think anyone knows that.

“So we have to be prepared that we’re in this for a while,” she said.

In the long term, Masci says countries must not “fall into the trap” of forgetting about the pandemic once it has passed.

“It is unnerving to think that this came without warning. It’s caused so much restructuring of everything.

“We have to have a more meticulous global search for new pathogens because we’re living in a time now where there is no, ‘Something is happening in Asia and it’s not going to happen in America.’”

ALSO READ  US In A Daring Move Fly Fighter Bombers Over North Korea
Continue Reading
Advertisement

Advertisement

Tweets by ‎@megaiconmagg

Subscribe to our Newsletter

* indicates required

MegaIcon Magazine Facebook Page

Advertisement

MEGAICON TV

Trending

%d bloggers like this: